Incretin-based therapies for type 2 diabetes mellitus: a review of direct comparisons of efficacy, safety and patient satisfaction

Author： Russell Sheldon  

Publisher： Springer Publishing Company

ISSN： 2210-7703

Source： International Journal of Clinical Pharmacy, Vol.35, Iss.2, 2013-04, pp. : 159-172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The incretin system in the management of type 2 diabetes mellitus

By Stephens Jeffrey W  

Clinical Medicine, Vol. 10, Iss. 5, 2010-10 ,pp. : 491-495

Royal College Of Physicians

Access to resources Recommend Favorite

New Approaches to Treating Type 2 Diabetes Mellitus in the Elderly: Role of Incretin Therapies

By Abbatecola Angela M.  

Drugs & Aging, Vol. 25, Iss. 11, 2008-01 ,pp. : 913-925

Adis International

Access to resources Recommend Favorite

Pharmacological profile, efficacy and safety of lixisenatide in type 2 diabetes mellitus

By Forst Thomas   Pfützner Andreas  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 16, 2013-11 ,pp. : 2281-2296

Informa Healthcare

Access to resources Recommend Favorite

Non-glycemic effects of pioglitazone and incretin-based therapies

By Rizzo Manfredi  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 7, 2013-10 ,pp. : 739-742

Informa Healthcare

Access to resources Recommend Favorite

Incretin-Based Therapies, Glucometabolic Health and Endovascular Inflammation

By  

Current Pharmaceutical Design, Vol. 20, Iss. 31, 2014-09 ,pp. : 4953-4960

Bentham Science Publishers

Access to resources Recommend Favorite